Metabolic & Endocrine Research
Type 2 Diabetes
Type 2 Diabetes affects millions of individuals worldwide and continues to be one of the fastest-growing chronic health conditions. CenExel partners with sponsors to advance innovative diabetes therapies through high-quality clinical research, experienced investigators, and diverse patient populations focused on improving long-term metabolic health outcomes.
Studies Conducted
0
+
Trial Participants
0
+
Active Sites
0
+
Overview
Advancing Type 2 Diabetes Clinical Research
CenExel delivers specialized clinical research solutions for Type 2 Diabetes and metabolic disorders. Our experienced investigators and research teams support sponsors with efficient trial execution, patient recruitment, and scientifically driven protocols from early-phase studies through post-market research.
Conditions Covered
Metabolic Conditions We Research
Our metabolic research sites support a wide range of diabetes and endocrine-related studies across adult and aging populations.
- Type II Diabetes
- Obesity & Weight Management
- Insulin Resistance
- Metabolic Syndrome
- Prediabetes
- Diabetic Neuropathy
- Cardiometabolic Disorders
- Hypertension
Our Approach
Why Sponsors Choose CenExel for Type 2 Diabetes
CenExel’s metabolic research network combines scientific expertise, advanced patient recruitment, and strong site performance to support successful diabetes clinical trials.
01
Experienced Metabolic Investigators
Our physicians and research teams specialize in diabetes, obesity, and endocrine disorders.
02
Diverse Patient Recruitment
Access broad and diverse patient populations for improved enrollment efficiency.
03
Advanced Biomarker Support
Comprehensive metabolic testing and biomarker strategies support accurate clinical insights.
04
Proven Enrollment Performance
Our sites consistently deliver high-quality enrollment and retention across metabolic studies.
Phase Coverage
Supported Trial Phases
CenExel supports early and late-phase metabolic and diabetes clinical trials — from first-in-human studies through Phase IV post-market research.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our experienced metabolic research teams provide operational excellence, centralized recruitment strategies, and data-driven patient engagement solutions.
Metabolic Task Force
CenExel supports a broad network of metabolic and endocrine research sites specializing in diabetes, obesity, cardiometabolic disease, and related chronic health conditions.
Active Sites
18 Sites
CenExel Phoenix
CenExel Anaheim
CenExel Atlanta
CenExel Marlton
CenExel Gaithersburg
